XZMD:LSE:LSE-Xtrackers MSCI USA ESG UCITS ETF 1D (USD)

ETF | Others |

Last Closing

USD 10.485

Change

0.00 (0.00)%

Market Cap

USD 0.15B

Volume

8.63K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 640.06B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 269.13B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
0QZ1:LSE AT&T Inc.

N/A

USD 171.96B
JT13:LSE UBS ETF - Bloomberg Barclays J..

N/A

USD 131.55B

ETFs Containing XZMD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.27% 37% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.27% 35% F 40% F
Trailing 12 Months  
Capital Gain 10.46% 70% C- 67% D+
Dividend Return 0.42% 36% F 42% F
Total Return 10.88% 69% C- 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.66% 76% C+ 78% C+
Dividend Return 14.82% 76% C+ 78% C+
Total Return 0.16% 38% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 13.23% 52% F 70% C-
Risk Adjusted Return 111.96% 94% A 96% N/A
Market Capitalization 0.15B 55% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.